Cargando…

A Is for Amyloid

Detalles Bibliográficos
Autor principal:	Selkoe, D. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182734/ https://www.ncbi.nlm.nih.gov/pubmed/32463063 http://dx.doi.org/10.14283/jpad.2020.27

Ejemplares similares

If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?
por: Haass, Christian, et al.
Publicado: (2022)

The amyloid hypothesis of Alzheimer's disease at 25 years
por: Selkoe, Dennis J, et al.
Publicado: (2016)

How do Soluble Oligomers of Amyloid β-protein Impair Hippocampal Synaptic Plasticity?
por: Li, Shaomin, et al.
Publicado: (2010)

Enriched environment enhances β‐adrenergic signaling to prevent microglia inflammation by amyloid‐β
por: Xu, Huixin, et al.
Publicado: (2018)

The amyloid-beta forming tripeptide cleavage mechanism of γ-secretase
por: Bolduc, David M, et al.
Publicado: (2016)

Amyloids in synthetic applications
por: Török, Marianna
Publicado: (2022)

Natural Inhibitors of Amyloid Aggregation
por: Tortora, Paolo, et al.
Publicado: (2023)

Beyond amyloid: altered gene function in neurodegenerative diseases
por: Yesiltepe, Metin, et al.
Publicado: (2023)

Amyloid-β breaks brain's neuroprotection
por: Wang, Yunling, et al.
Publicado: (2017)

Pathological and Functional Amyloid Fibrils—Part I
por: Kuznetsova, Irina M., et al.
Publicado: (2022)

Amyloid beta dimers/trimers potently induce cofilin-actin rods that are inhibited by maintaining cofilin-phosphorylation
por: Davis, Richard C, et al.
Publicado: (2011)

Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid
por: Yang, Ting, et al.
Publicado: (2019)

Reducing Amyloid Plaque Burden via Ex Vivo Gene Delivery of an Aβ-Degrading Protease: A Novel Therapeutic Approach to Alzheimer Disease
por: Hemming, Matthew L, et al.
Publicado: (2007)

Beyond amyloid: New approaches to Alzheimer's disease treatment
Publicado: (2020)

The Contribution of the Amyloid Hypothesis to the Understanding of Alzheimer's Disease: A Critical Overview
por: Morelli, Laura, et al.
Publicado: (2012)

Understanding Amyloid Structures and Disease: A Continuing Challenge in Health Research
por: Chiellini, Grazia
Publicado: (2021)

Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions
por: Greenberg, Barry D., et al.
Publicado: (2023)

Not all cortical cerebral microbleeds are due to cerebral amyloid angiopathy
por: Gerraty, Richard
Publicado: (2021)

Amyloid-β: Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases
por: Saito, Satoshi, et al.
Publicado: (2022)

Why do anti-amyloid beta antibodies not work? Time to reconceptualize dementia pathophysiology by incorporating astrocyte melatonergic pathway desynchronization from amyloid-beta production
por: Anderson, George
Publicado: (2023)

Anti-amyloid agents for treating incipient Alzheimer’s disease: a new hope?
por: Loureiro, Julia C., et al.
Publicado: (2022)

Beyond One-Trick Ponies: The Multifunctional Marvels of Microbial Functional Amyloids
por: Landau, Meytal
Publicado: (2023)

Amyloid β and Alzheimer’s Disease: Molecular Updates from Physiology to Pathology
por: Giuffrida, Maria Laura
Publicado: (2023)

Editorial: A Time of Transition of Alzheimer's Disease in the Advent of Anti-Amyloid Monoclonal Antibodies
por: Tousi, Babak, et al.
Publicado: (2021)

Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy
por: Fontana, Marianna, et al.
Publicado: (2023)

Plasma levels of serum amyloid A1 and mortality after exposure to high-dose radiation
por: Klokov, Dmitry
Publicado: (2020)

News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer’s disease in 2023
por: Gandy, Sam
Publicado: (2023)

Editorial: Targets for Disease-Modifying Therapies in Alzheimer’s Disease, Including Amyloid β and Tau Protein
por: Parums, Dinah V.
Publicado: (2021)

A calcium-sensitive antibody isolates soluble amyloid-β aggregates and fibrils from Alzheimer’s disease brain
por: Stern, Andrew M, et al.
Publicado: (2022)

Recent Insight in Islet Amyloid Polypeptide Morphology, Structure, Membrane Interaction, and Toxicity in Type 2 Diabetes
por: Khemtemourian, Lucie, et al.
Publicado: (2016)

FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
por: Verger, Antoine, et al.
Publicado: (2023)

Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity
por: Welzel, Alfred T., et al.
Publicado: (2014)

Editorial to •Trends, burden, and impact of arrhythmia on cardiac amyloid patients: A 16‐year nationwide study from 1999 to 2014•
por: Suenari, Kazuyoshi
Publicado: (2020)

Importance of Aggregated Islet Amyloid Polypeptide for the Progressive Beta-Cell Failure in Type 2 Diabetes and in Transplanted Human Islets
por: Westermark, Gunilla T., et al.
Publicado: (2008)

CSF β-amyloid and white matter damage: unravelling the neuropathology of Alzheimer’s disease
por: Sousa Alves, Gilberto
Publicado: (2018)

A coalescent sampler successfully detects biologically meaningful population structure overlooked by F‐statistics
por: Crandall, Eric D., et al.
Publicado: (2018)

A New Method for Quantitative Immunoblotting of Endogenous α-Synuclein
por: Newman, Andrew J., et al.
Publicado: (2013)

Amyloid Imaging in Aging and Dementia: Testing the Amyloid Hypothesis In Vivo
por: Rabinovici, G. D., et al.
Publicado: (2009)

Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease
por: Villemagne, Victor L., et al.
Publicado: (2012)

Peritoneal Amyloid as a Presenting Manifestation of AL Amyloid
por: Acharya, Indira, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s9rm633lp0joqvailsj128usbb